NB
GSK icon

Nicolet Bankshares’s GSK GSK Stock Holding History

Nicolet Bankshares’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.53M Buy
45,512
+26,867
+144% +$1.46M 0.09% 165
2025
Q4 		$914K Sell
18,645
-7,567
-29% -$353K 0.15% 105
2025
Q3 		$1.13M Buy
26,212
+1,093
+4% +$42.7K 0.18% 90
2025
Q2 		$965K Buy
25,119
+1,126
+5% +$43K 0.17% 92
2025
Q1 		$929K Sell
23,993
-1,240
-5% -$45.4K 0.19% 90
2024
Q4 		$853K Sell
25,233
-1,569
-6% -$56.5K 0.2% 98
2024
Q3 		$1.1M Buy
26,802
+670
+3% +$27.4K 0.27% 83
2024
Q2 		$1.01M Sell
26,132
-973
-4% -$40.9K 0.25% 86
2024
Q1 		$1.16M Buy
27,105
+289
+1% +$11.9K 0.29% 83
2023
Q4 		$994K Buy
26,816
+1,903
+8% +$68.3K 0.27% 89
2023
Q3 		$903K Sell
24,913
-9,791
-28% -$348K 0.28% 82
2023
Q2 		$801K Buy
34,704
+25,402
+273% +$911K 0.23% 90
2023
Q1 		$331K Sell
9,302
-2,105
-18% -$73.6K 0.11% 146
2022
Q4 		$401K Buy
+11,407
New +$380K 0.14% 122

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Nicolet Bankshares's GSK Position: Q1 2026 in Review

Nicolet Bankshares increased its GSK (GSK) stake by 144% in Q1 2026, buying an estimated $1.46M and bringing the position to 45,512 shares worth $2.53M. The position accounts for 0.09% of the portfolio, ranked #165.

Nicolet Bankshares first reported a position in GSK in Q4 2022 and has held it in 14 quarters since. 1,033 funds tracked by Wall St. Rank hold GSK as of Q1 2026.

  • Nicolet Bankshares held 45,512 shares of GSK worth $2.53M as of Q1 2026.
  • Nicolet Bankshares bought 26,867 GSK shares in Q1 2026, an estimated $1.46M.
  • GSK made up 0.09% of Nicolet Bankshares's portfolio in Q1 2026, its #165 holding.
  • Nicolet Bankshares first reported a position in GSK in Q4 2022 and has held it in 14 quarters since.
  • 1,033 funds tracked by Wall St. Rank held GSK as of Q1 2026.

Based on Nicolet Bankshares's 13F filing for Q1 2026, filed 14 May 2026.